Single-Cell Analysis Reveals Immune Dynamics of Moderna COVID-19 Vaccine in Pregnant Women
Key Insights
Researchers conducted the first single-cell transcriptomic study of immune responses to Moderna mRNA COVID-19 (search) vaccine in three pregnant women, revealing distinct cellular dynamics during vaccination.
The study found that the first vaccine dose triggered transient activation of proinflammatory monocytes and T cell responses, while B cell activation was delayed until after the second dose.
Anti-SARS-CoV-2 (search) IgG antibodies remained undetectable after the first dose but reached maximum levels (250 U/mL) following the second vaccination, demonstrating effective humoral immunity despite pregnancy.
A groundbreaking single-cell RNA sequencing study has mapped the immune responses of pregnant women to the Moderna mRNA COVID-19 (search) vaccine, providing unprecedented insights into how vaccination affects maternal immunity at the cellular level. The research, published in Genes & Immunity, represents the first comprehensive transcriptomic analysis of vaccine-induced immune dynamics during pregnancy.
Study Design and Methodology
The study enrolled three pregnant women who received two doses of Moderna mRNA-1273 (search) (Spikevax) vaccine. Researchers collected peripheral blood mononuclear cells (PBMCs) and serum samples at four critical timepoints: before vaccination (T1), 6 days after the first dose (T2), 13 days after the first dose (T3), and more than 2 months after the first dose following the second vaccination and delivery (T4).
Using 10x Genomics (search) single-cell RNA sequencing technology, the team analyzed 11,731 individual immune cells, identifying 16 transcriptionally distinct clusters that were grouped into 11 canonical immune cell types including monocytes, T cells, B cells, dendritic cells, and NK cells.
Antibody Response Timeline
Anti-SARS-CoV-2 (search) IgG antibody measurements revealed a delayed but robust humoral response. No antibodies were detected at T1 and T2, with only modest levels (17.6 U/mL average) appearing at T3. However, by T4, antibody concentrations reached the upper detection limit of 250 U/mL in all participants, indicating that while a single dose was insufficient for strong antibody production, the second dose generated substantial immune protection.
Monocyte Dynamics and Innate Immunity
The analysis revealed sophisticated monocyte subset dynamics following vaccination. Classical monocytes were further classified into three subsets (cM_1, cM_2, cM_3) and nonclassical monocytes (ncM). The cM_1 subset, characterized by high expression of proinflammatory genes including IL1B (search), NLRP3 (search), and NFKB1 (search), showed a transient increase at T2 before returning to baseline levels by T3.
Gene set variation analysis demonstrated that cM_1 served as the primary inflammatory effector subset, enriched in inflammatory and T cell activation pathways. Differential expression analysis comparing T2 with T1 revealed enrichment in lymphocyte differentiation, TGF-β (search) response, and metabolic regulation pathways, suggesting that monocytes participated in immune coordination without triggering excessive inflammation.
At T4, following the second dose and delivery, the cM_1 population was largely replaced by cM_2, which retained some inflammatory functions but showed reduced expression of key inflammatory markers. This shift likely reflected both vaccine-induced responses and pregnancy-associated immune remodeling toward tissue repair and metabolic regulation.
T Cell Activation and Memory Formation
T cell analysis identified eight distinct subtypes, including three CD4 (search)+ subsets, three CD8 (search)+ subsets, one NKT subset, and one NK subset. Despite the immunoregulatory environment of pregnancy, T cells demonstrated robust activation and differentiation capabilities following vaccination.
At T2, T cells showed significant upregulation of genes involved in activation and metabolism, including RPS26, LEPROTL1, CREM, and ICOS, along with enrichment of pathways related to CD4 (search)-positive T cell activation and proliferation. By T3, T cells displayed a distinct transcriptional profile enriched for pathways associated with energy metabolism and mitochondrial activity, indicating a transition toward functionally mature memory states.
The researchers observed that naive T cells gradually differentiated into central memory (Tcm) and effector memory (Tem) subsets, with CD4 (search)+ Tcm serving as a major source of long-term immunological memory, consistent with patterns observed in non-pregnant populations.
B Cell Response Patterns
B cells were classified into three main subtypes: naive B cells, memory B_GRP183, and memory B_ITGB1. Unlike monocytes and T cells, which showed early transcriptional changes, B cells exhibited no significant differential gene expression at T2 or T3, aligning with the delayed antibody response observed in serum measurements.
Functional analysis revealed that naive B cells displayed low activity across most pathways, while memory B cell subsets showed enrichment in lipid metabolism, immune regulation, and TLR signaling pathways. The delayed B cell response likely reflected the immunosuppressive environment of pregnancy, where B cell frequency and activation markers are naturally reduced to maintain maternal-fetal immune tolerance.
Clinical Implications and Safety Profile
The study's findings provide mechanistic support for current public health recommendations regarding COVID-19 (search) vaccination during pregnancy. The research demonstrated that pregnant women can mount coordinated immune responses without excessive inflammation, reinforcing vaccine safety during pregnancy.
"Through single-cell transcriptomic profiling, this study revealed distinct immune dynamics in pregnant women during vaccination," the researchers noted. "After the first vaccine dose, innate immune activation was evident, marked by a transient increase in proinflammatory monocytes, yet the overall immune response remained controlled, without excessive inflammation."
The controlled immune activation observed in the study contrasts with the more pronounced inflammatory responses typically seen during COVID-19 (search) infection, suggesting that vaccination provides immune protection while maintaining the delicate immunological balance required during pregnancy.
Study Limitations and Future Directions
The researchers acknowledged several limitations, including the small sample size of three participants, which constrained generalizability and assessment of inter-individual variability. Cell damage from cryopreservation also resulted in suboptimal cell recovery in some samples, potentially limiting detection of rare immune subsets.
Additionally, the final timepoint (T4) was collected after both the second vaccination and delivery, making it difficult to distinguish whether observed immune changes were primarily driven by vaccination or physiological effects of childbirth.
Despite these limitations, the study represents a significant advancement in understanding vaccine-induced immunity during pregnancy. The researchers emphasized that their work provides "the most accurate representation of the available data" and offers valuable insights into the unique immunological landscape of pregnancy in the context of COVID-19 (search) vaccination.